Compounds > exp3174
Page last updated: 2024-09-02

exp3174 and Sclerosis, Systemic

exp3174 has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldsmith, DJ1

Other Studies

1 other study(ies) available for exp3174 and Sclerosis, Systemic

ArticleYear
Angiotensin receptor antagonists.
    Lancet (London, England), 1997, Apr-26, Volume: 349, Issue:9060

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Humans; Hypertension; Imidazoles; Losartan; Scleroderma, Systemic; Tetrazoles

1997